Patent · US Active

Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV

US8236810B2 · kind B2 · utility

0Cited by

4References

4Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Karl Schoenafinger · Alzenau, DE
Gerhard Jaehne · Frankfurt, DE
Elisabeth Defossa · Idstein, DE
Guenter Billen · Frankfurt am Main, DE
Christian Buning · Frankfurt am Main, DE
Georg Tschank · Frankfurt am Main, DE
Ulrich Werner · Frankfurt am Main, DE

Key dates

Filing date	Jan 11, 2007
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Mar 2, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention 8-aminothioxanthines and the derivatives of formula Iwherein the various R groups and substituents are comprised of a number of different (C1-C10)-alkyl, cycloalkyl, aryl, alkene, alkyne, etc. groups and derivatives thereof which are hereinafter more specifically defined for the treatment of metabolic disorders such as type-2 diabetes, hyperglycemia, arteriosclerotic diseases and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.